Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.

Authors:
Pathare A; Taher A; Daar S.

Journal:
Ann Hematol

Publication Year: 2009

DOI:
10.1007/s00277-009-0838-z

PMCID:
PMC2824843

PMID:
19798501

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ann Hematol

Abbreviation: Ann Hematol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A convenient and practical index for predicting the induction response in adult patients with hemop…
Feng C; Hua Z; He L and 5 more (2024) - Transparency Score: 3/6
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicent…
Gabellier L; Peterlin P; Thepot S and 16 more (2024) - Transparency Score: 3/6
The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell t…
Wu X; Ma X; Song T and 3 more (2024) - Transparency Score: 3/6
Alternative treatment modality for severe aplastic anemia in a resource-limited setting: a single-i…
Youssef MAM; Ghazaly MH; Abdelfattah MA. (2023) - Transparency Score: 3/6
Analysis of hematologic adverse events reported to a national surveillance system following COVID-1…
Jacobs JW; Booth GS; Adkins BD. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"Financial support for medical editorial assistance was provided by Novartis Pharmaceuticals. We thank Dr. Rebecca Helson for medical editorial assistance with this manuscript."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025